Aleks Engel speaking at World Antimicrobial Resistance Congress

Aleks Engel, Director,
REPAIR Impact Fund, Novo Holdings


What do you see as the biggest challenges facing the AMR space into 2022? 

  • Loss of further talent to other therapeutic areas due to lack of funding 
  • Further bankruptcies that will further scare away investors 


If you could wave a magic wand, what would you like to see occur in the coming year to further combat AMR? 

  • The passage of the PASTEUR Act.  We absolute need it 
What would you like to highlight about your work/your organization for this coming year? 
  • We are working on closing two new investments in Q1 
  • We will open the REPAIR Impact Fund 2022 call for proposals in May 
Do you have any predictions for the AMR space in 2022 and beyond? Any calls-to-action you’d like to highlight? 
  • The G7 finance ministers will realize that without reimbursement reform their countries will not get access to new drugs will finally move on subscription models 





To Sponsor Or Exhibit


Semen Sen
+1 646.619.1793



To Speak


Emma Goaley
+1 646.400.2576



Press & Media Partnerships


Ipek Coskun
+1 407.421.5818